Quarterly report pursuant to Section 13 or 15(d)

Stock based compensation, options and warrants (Tables)

v3.19.1
Stock based compensation, options and warrants (Tables)
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of Recognized Stock-based Compensation
The Company recognized total stock-based compensation expense during the three months ended March 31, 2019 and 2018, from the following categories:

   
Three Months Ended March 31,
 
   
2019
   
2018
 
Restricted stock awards under the Plan
 
$
176,544
   
$
766,949
 
Stock option awards under the Plan
   
58,498
     
116,994
 
    Total stock-based compensation
 
$
235,042
   
$
883,943
Summary of Restricted Plan Activity
A summary of the Company’s unvested restricted stock activity in the three months ended March 31, 2019 is presented here:
 
   
Number of Shares
   
Weighted Average Grant-Date
Fair Value
 
Unvested at January 1, 2018
   
95,939
   
$
12.49
 
Vested
   
(22,397
)
 
$
9.37
 
Forfeited
   
(40,000
)
 
$
16.82
 
Unvested at March 31, 2019
   
33,542
   
$
9.39
 
Summary of Stock Incentive Plan Activity
A summary of activity under the Plan for the three months ended March 31, 2019 is presented below:
 
   
Shares Underlying Options
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2019
   
62,000
   
$
15.71
     
9.2
   
$
-
 
Outstanding at March 31, 2019
   
62,000
   
$
15.71
     
9.0
   
$
-
 
                                 
Exercisable at March 31, 2019
   
62,000
   
$
15.71
     
9.0
   
$
-
 
Schedule of Changes in Outstanding Warrants
Following is a summary of outstanding options and warrants that were issued outside of the Plan for the three months ended March 31, 2019:
 
   
Shares Underlying Options/Warrants
   
Weighted Average Exercise Price
   
Weighted Average Remaining Contractual
Term (Years)
   
Aggregate Intrinsic Value
 
Outstanding at January 1, 2019
   
1,671,113
   
$
39.47
     
2.0
   
$
-
 
Granted
   
1,908,144
   
$
1.94
     
5.2
   
$
2,537,832
 
Outstanding at March 31, 2019
   
3,579,257
   
$
19.46
     
3.6
   
$
2,537,832
 
                                 
Exercisable at March 31, 2019
   
3,579,257
   
$
19.46
     
5.2
   
$
2,537,832